Sees 2024 non-GAAP operating earnings $80M-$110M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SUPN:
- Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
- Supernus Pharmaceuticals (SUPN) Q4 Earnings Cheat Sheet
- Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024
- Supernus Pharmaceuticals Wins Patent Infringement Lawsuit
- Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent